Refugees Denied Cancer Treatments Due To Steep Medical Costs, Study Says

News outlets report on a study published in Lancet Oncology on access to cancer treatments for Iraqi and Syrian refugees.

Agence France-Presse: Syria refugees denied cancer treatment, says UNHCR
“Lack of funds is forcing aid workers to deny Syrian war victims and other refugees with cancer the care they need, the U.N. refugee agency’s top medical expert warned on Monday. … In a new study published in the journal The Lancet Oncology, [UNHCR’s medical chief, Paul] Spiegel, documented hundreds of refugees in Jordan and Syria [who were] denied cancer treatment due to limited funds, and called for urgent new steps to tackle cancer in humanitarian crises…” (Fowler, 5/25).

Agence France-Presse: Steep medical bill for hosts of Iraqi, Syrian refugees
“Middle Eastern countries that host refugees from conflict-torn Iraq and Syria are having to deal with a steep health care bill from expensive-to-treat chronic diseases like cancer, a study said Monday…” (5/25).

BBC News: Refugees ‘struggle for cancer care’
“There is a ‘high demand’ for cancer treatment from refugees, which is often difficult to meet, experts say. Infectious diseases and malnutrition have understandably been the focus of refugee health work. But in Lancet Oncology, the United Nations High Commissioner for Refugees says cancer is a major issue that host countries often struggle to deal with…” (5/25).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.